Awards for January 2017
Albanesi, Joseph, NIH, Mechanism and Function of Arc Palmitoylation, $182,250; Alto, Neal, NIH, Type III Effector Regulation of Host Signal Transduction Systems, $439,691; Amatruda, James, Children’s Hosp. Philadelphia/NIH, National Clinical Trials Network (NCTN) Grant - Project Every Child, $3,750; Brekken, Rolf, Houston Methodist Res Inst/NIH, Center for Immunotherapeutic Transport Oncophysics, $161,957; Castrillon, Diego, NIH, Genetic Studies of the Kit Receptor Tyrosine Kinase in Primordial Follicle Activation, $243,000; Chalak, Lina, Univ of Calif, San Francisco/NIH, HEAL Trial: High-Dose Erythropoietin for Asphyxia and Encephalopathy, $19,440; Chiang, Cheng-Ming, Univ of Iowa/NIH, Factors Involved in Transcription by RNA Polymerase II, $14,542; Dowling, Michael, Univ of Calif, San Francisco/NIH, The Vascular Effects of Infection in Pediatric Stroke (VIPS II) Study, $11,985;
Garcia, Christine, NIH, Mutant Surfactant - Induced TGF-beta Secretion in Lung Fibrosis, $459,473; Gimpel, Nora, Texas A&M Univ/HRSA, Dental Faculty Development and Loan Repayment Program, $14,028; Green, Carla, NIH, Circadian Dynamics of Cytoplasmic mRNA Polyadenylation and Deadenylation, $315,102; Haley, Robert, Emory Univ/Dept of Defense, Exploring Mechanisms Underlying Impaired Brain Function in GWI, $70,152; Herz, Joachim, NIH, Metabolism of the VLDL Receptor and ApoE Receptor, $400,950; Herz, Joachim, NIH, Molecular Basis of Synaptic Suppression by ApoE, $364,500; Hobbs, Helen, NIH, Role of ABCG5 and ABCG8 in Sterol Metabolism, $468,454;
Hsieh, Jenny, NIH, Targeting Aberrant Neurogenesis to Prevent Epilepsy and Associated Cognitive Decline, $318,937; Jain, Mamta, Virginia Commonwealth Univ/NIH, HBV-HIV Coinfection Research Network, $70,217; Journeycake, Janna, UT HSC Houston/CDC, Community Counts: Public Health Surveillance for Bleeding Disorders, $21,756; Kitchell, Ellen, Texas Dept State Health Svc/CDC, HIV/PREVF HIV-Prevention Services, $200,800; Kohler, Jennifer, NIH, Study of Sialoside Function Using Photocrosslinking Sialic Acid, $329,130; Laetsch, Theodore, Univ of Colorado/NIH, Phase I/Ib Study of Eribulin with Oral Irinotecan for Adolescent and Young Adult Pts with Solid Tumors, $15,000; Lai, Helen, NIH, Probing the Origin and Function of a Novel Subset of Motor Neurons, $243,000; Le, Lu Quang, Indiana Univ/NIH, Developmental and HyperActive Ras Tumor SPORE, $86,935; Lee, William, Univ of Michigan/NIH, Chronic Hepatitis B Patients with Concurrent HBsAg and Anti-HBs, $18,393;
Liu, Xin, NIH, Structural Basis of Gene Regulation, $310,154; Luo, Xuelian, Massachusetts Genl Hosp/NIH, Chemical Approach to Study Autopalmitoylation of Transcription Factors, $104,736; Madden, Christopher, Univ of Calif, San Francisco/NIH, Transforming Research and Clinical Knowledge (TRACK TBI), $166,302; Maldjian, Joseph, Wake Forest Univ/NIH, Alzheimer's Disease Core Center (ADCC), $80,957; Malloy, Craig, NIH, National Center for In Vivo Metabolism, $1,714,597; Mani, Ram, NIH, Tracing the Origins of Chromosomal Translocations in Prostate Cancer, $249,000; Norgard, Michael, NIH, Structure and Function of Treponema Pallidum Lipoprotein, $584,225; Norgard, Michael, NIH, The RpoN-RpoS Regulatory Pathway in Borrelia Burgdorferi, $453,367;
Oh, Dayoung, NIH, Feed-Forward Regulation Between GPR120 and PPAR Gamma, $405,000; Pan, Duojia, US Dept of Defense, Hippo Signaling in Polycystic Kidney Disease, $245,078; Pasare, Chandrashekhar, NIH, Role of BCAP in Regulating Inflammation and Adaptive Immunity, $405,000; Patel, Ashish, Weill Cornell Medical Coll/NIH, Sex Differences in Statural Growth Impairment in Pediatric Crohn's Disease, $54,270; Perez-Fontan, Julio, NIH, Antecedants Sequelae of Childhood Onset Disease, $201,716; Phillips, Margaret, NIH, Lead Optimization of DHODH Inhibitors for Malaria, $595,447; Phillips, Margaret, NIH, Targeting Trypanosomatid Deoxyhypusine Synthase, $243,000;
Rizo-Rey, Jose, NIH, Mechanisms of Neurotransmitter Release and Its Regulation, $540,350; Rosenbaum, Daniel, NIH, Molecular Mechanism of a Master Regulator of Sterol Homeostasis, $277,893; Rutherford, Cynthia, UT HSC Houston/CDC, CDC Community Counts Project, $18,338; Sahoo, Sunati, Texas A&M Univ/NIH, Target Identification and Validation to Overcome Antiestrogen Resistance in ER+, $10,512; Shaul, Philip, NIH, Dichotomous Role of Endothelial SR-BI in Atherosclerosis, $405,000; Shaul, Philip, Univ of Illinois/NIH, Novel Ligands and Mechanisms to Achieve Selective Nuclear Receptor Activity, $112,136; Skinner, Celette, NIH, National Survey on Oncologist Reimbursement & EHR-Based Tools, $499,538;
Sperandio, Vanessa, NIH, Quorum Sensing Regulation of EHEC Virulence Genes, $546,834; Sternweis, Paul, NIH, Signal Transduction Via Receptors and G Proteins, $442,926; Stowe, Ann, NIH, B Cells Alter Adaptive Autoimmunity to Protect from Ischemic Injury After Stroke, $387,645; Tu, Benjamin, NIH, Metabolic Signals Driving Cell Growth & Proliferation, $333,120; Turer, Christy, NIH, Primary Care, Communication & Improving Children's Health, $168,050; Van Oers, Nicolai, NIH, Long Noncoding RNAs, $432,410;
Wang, Yingfei, NIH, The Role of a Novel AIF-Associated Nuclease PAAN1 in Neuronal Injury, $224,100; Wang, Zhigao (Fellow E. Reynoso), NIH, Biochemical Dissection of the Execution Step of Mammalian Necrotic Cell Death, $31,159; Williams, Brian, Univ of Washington/NIH, Policy Relevant U.S. Trauma Care System Pragmatic Trial for PTSD and Comorbidity, $8,075; Yu, Gang, NIH, Gamma-Secretase and Myelin: A Paradigm Shift in Brain Disorders, $313,031; Zhang, Chengcheng, NIH, The Role of Inhibitory Receptors in Leukemia Development, $296,932; Zigman, Jeffrey, Texas A&M HSC/NIH, Dysregulated Hypothalamic-Pituitary-Adrenal Axis During Biliary Hyperplasia, $14,012.
Akbay, Esra, CPRIT, Recruitment of First-Time, Tenure-Track Faculty Members, $461,766; Alto, Neal, Burroughs Wellcome Fund, Seminar Award - Dr. John Boothroyd, $1,000; Chahrour, Maria, NARSAD, The Role of UBE3B in the Pathogenesis of Autism Spectrum Disorder, $35,000; Chang, Audrey, Amer Heart Assoc, Cell Signaling Mechanisms to Cardiac Myosin Phosphorylation, $77,000; Covin, Yvonne, Univ of Texas System, Investigating Validity of Clinical Reasoning Rubrics in Assessment of Medical Student SOAP Notes, $1,045; Friedman, Deborah (Fellow S. Smith), Fight for Sight Res, Characterizing Ocular Motor Abnormalities in Patients with Vestibular Migraines, $3,000; Grishin, Nick, CPRIT, Prediction of Nuclear Export Signals in Proteins, $281,663; Gupta, Rana, Amer Diabetes Assoc, Defining the Contribution of Mural Cell Adipogenesis, $115,000;
Herz, Joachim, Bluefield Project to Cure FTD, Progranulin Enhancing Drug Discovery and GRN Lipidomics, $225,000; Jain, Raksha, Cystic Fibrosis Fdn, Therapeutics Development Center, $123,363; Jain, Raksha, Cystic Fibrosis Fdn, Adult Therapeutics Development Network Additional Research Coordinator Award, $27,123; Jain, Raksha, Cystic Fibrosis Fdn, Proposal for Additional PI Protected Effort, $24,210; James, Kassidy, Physician Assistant Educ Assoc, Utilization of Multiple Mini-Interviews (MMI) within Admission Processes of Physician Assistant Programs, $5,330; Kehoe, Siobhan, UT MD Anderson/CPRIT, Early Detection of Ovarian Cancer with Tumor Associated Proteins and Autoantibodies, $31,579; Kraus, William (Fellow R. Gupte), Amer Heart Assoc, PARP-1 in Macrophages, $52,244; Laetsch, Theodore, Dana-Farber Cancer Inst, GAIN iCat2 - Outcomes of Targeted Therapy Matched to an Individual, $10,000;
Le, Lu Quang, Johns Hopkins Univ/Bloomberg Fdn, A Robust Plexiform Neurofibroma Model for Preclinical Drug Screening, $197,670; Lega, Bradley, Univ of Pennsylvania/DARPA, Brain Recording and Stimulation for Memory - Yr 2, $230,000; MacMillan, John, CPRIT, Natural Product for Treatment of Non Small Cell Lung Cancer, $262,984; Nam, Yunsun (Fellow P. Wang), Amer Heart Assoc, Structural and Mechanistic Studies of m6A Methylation on miRNA by Mettl3/Mettl14 Complex, $48,600; Nijhawan, Deepak, Harrington Discovery Inst, Optimizing the Anti-Tumor Toxin CD437 for Pre-Clinical Drug Development, $50,001; Olson, Eric, Fondation Leducq, Programming the Failing Heart to a Regenerative State, $158,365;
Oz, Orhan, Amer Diabetes Assoc, Osteomyelitis: Evaluating SPECT CT and Bone Biopsy, $200,000; Pasare, Chandrashekhar (Fellow K. Deason), Amer Heart Assoc, The Role of BCAP in Obesity Induced Diabetes, $25,950; Patel, Ashish, Emory Univ/Crohn & Colitis Fdn, Risk Stratification and Identification of Immunogenetic and Microbial Markers in Pediatric Crohn's Disease, $10,120; Rosen, Michael (Fellow F. Rustam Ali), Amer Heart Assoc, NMR Studies of Actin Monomer Dynamics and Their Roles in Actin Filament Dynamics, $50,432; Rosenbaum, Daniel (Fellow L. Clark), Amer Heart Assoc, Structural Mechanism of Cholesterol Homeostasis by Scap, $26,000; Sathe, Meghana, Cystic Fibrosis Fdn, TDC Additional Research Coordinator Award, $54,514; Sepdham, Dan, Texas Academy of Family Physicians Fdn, Preceptorship Program, $5,000;
Sharma, Preeti, Cystic Fibrosis Fdn, TX-34/34 - Children's Medical Center of Dallas, $174,650; Tamminga, Carol (Fellow D. Scott), NARSAD, Neuronal Activity Within Hippocampal Subfields: Effects on Psychosis-Related Behavior, $32,500; Tu, Benjamin, CPRIT, Evaluation of the Role of Tumor Suppressor Candidate NPRL2 in Cell Growth Control, $202,210; Wakeland, Edward, Alliance for Lupus Res, Identifying Functional Variants that Underlie SLE Susceptibility, $190,119; Wang, Zhao, Amer Diabetes Assoc, Mechanism of Diabetic Cardiomyopathy: Role of the Unfolded Protein Response, $115,000; Welch, Babu, Univ of Louisville, ASTROH: Aneurysmal Subarachnoid Hemorrhage Trial Randomizing Heparin, $67,000; Whitehurst, Angelique, V Fdn for Cancer Res, Genetic Dissection of Therapeutic Intervention Targets in Triple Negative Breast Cancer, $100,000; Zhong, Qing, CPRIT, Primary Cilia in Cell Cycle Control and Tumorigenesis, $300,000.
Industry Sponsored Awards, dollar amounts not available
Bird, John Andrew, DBV Technologies, Phase 3 Study of Viaskin Peanut Epicutaneous Treatment in Peanut-Allergic Children; Corey, David, ProQR Therapeutics, Validation of in Vitro PoC Study; Garg, Abhimanyu, Aegerion Pharma, MEASuRE: Metreleptin Effectiveness and Safety Registry; Glazer, Craig, Boehringer Ingelheim Pharma, Study of Oral Nintedanib with Oral Sildenafil for Idiopathic Pulmonary Fibrosis; Khazzam, Michael, Wright Medical Technology, Pyrocarbon IDE Study; Pedrosa, Ivan, Philips Medical Systems, Evaluation of System Enhancements for Magnetic Resonance; Schaffer, Joseph, Icon Clinical Res/Astellas Pharma, Phase 4 Study of Mirabegron in Older Adults with Overactive Bladder.